Dec 03, 2025
Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric ConditionsVIEW RELEASE
Nov 12, 2025
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s DiseaseVIEW RELEASE
Oct 14, 2025
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy OutcomesVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Dec 05, 2025 12:55 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
2.1
CHANGE
0.02 (0.72%)
